On the mechanism of sequence-specific DNA-dependent acetylation of p53:: The acetylation motif is exposed upon DNA binding

被引:23
作者
Cesková, P
Chichgeri, H
Wallace, M
Vojtesek, B
Hupp, TR
机构
[1] Univ Edinburgh, CRUK Cell Signaling Unit, Edinburgh EH4 2XR, Midlothian, Scotland
[2] Masaryk Mem Canc Inst, Brno 65653, Czech Republic
基金
英国生物技术与生命科学研究理事会;
关键词
acetylation; p300; p53; sequence-specific DNA; conformation;
D O I
10.1016/j.jmb.2005.12.026
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
P53 acetylation requires p300-docking to two contiguous sites in the activation domain that in turn mediates DNA-dependent acetylation of the tetramer. In an attempt to further define the mechanism of DNA-dependent acetylation of p53, an in vitro system has been reconstituted with distinct p53 isoforms and has been used to reveal conformational constraints on p53 acetylation. Two native p53 tetrameric isoforms purified from Sf9 cells differing by the extent of phosphorylation within the C-terminal acetylation site are both acetylated in a sequence-specific DNA-dependent manner. By contrast, p53 purified from an Escherichia coli expression system is in a largely denatured conformation and its acetylation is DNA-independent. Heating native p53 to destroy the folded structure restores DNA-independent acetylation similar to that seen with bacterially expressed p53. There are at least two sites of conformational flexibility in the p53 tetramer: the first in the flexible S 10 beta-sheet within the MDM2 ubiquitination sequence and the second in the C-terminal regulatory domain. We analysed therefore whether DNA-dependent acetylation correlated with conformational changes in either of these two regions. DNA-dependent acetylation of p53 is maintained in a dose-dependent manner by low concentrations of consensus site DNA under conditions where flexibility in the S10 beta-sheet region is maintained. Oligonucleotide DNAs that promote acetylation stimulate the binding of monoclonal antibodies PAb421 and ICA-9; two antibodies whose contiguous epitopes overlap the C-terminal acetylation motif. By contrast, bent oligonucleotide DNAs that conceal both the S10 beta-sheet from binding of the monoclonal antibody DO-12 and attenuate binding of the monoclonal antibody PAb421 can preclude acetylation. These data suggest that, in the absence of DNA, the acetylation motif of p53 is in a cryptic state, but after DNA binding, allosteric effects mediate an exposure of the acetylation motif to allow DNA-dependent acetylation of the tetramer. (c) 2005 Published by Elsevier Ltd.
引用
收藏
页码:442 / 456
页数:15
相关论文
共 42 条
[1]   Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases [J].
Barlev, NA ;
Liu, L ;
Chehab, NH ;
Mansfield, K ;
Harris, KG ;
Halazonetis, TD ;
Berger, SL .
MOLECULAR CELL, 2001, 8 (06) :1243-1254
[2]   Chk1 and Chk2 kinases in checkpoint control and cancer [J].
Bartek, J ;
Lukas, J .
CANCER CELL, 2003, 3 (05) :421-429
[3]   A single nucleotide polymorphism in the MDM2 gene:: From a molecular and cellular explanation to clinical effect [J].
Bond, GL ;
Hu, WW ;
Levine, A .
CANCER RESEARCH, 2005, 65 (13) :5481-5484
[4]   A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans [J].
Bond, GL ;
Hu, WW ;
Bond, EE ;
Robins, H ;
Lutzker, SG ;
Arva, NC ;
Bargonetti, J ;
Bartel, F ;
Taubert, H ;
Wuerl, P ;
Onel, K ;
Yip, L ;
Hwang, SJ ;
Strong, LC ;
Lozano, G ;
Levine, AJ .
CELL, 2004, 119 (05) :591-602
[5]   Increased sensitivity to UV radiation in mice with a p53 point mutation at Ser389 [J].
Bruins, W ;
Zwart, E ;
Attardi, LD ;
Iwakuma, T ;
Hoogervorst, EM ;
Beems, RB ;
Miranda, B ;
van Oostrom, CTM ;
van den Berg, J ;
van den Aardweg, GJ ;
Lozano, G ;
van Steeg, H ;
Jacks, T ;
de Vries, A .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (20) :8884-8894
[6]   Biochemical characterization of different conformational states of the Sf9 cell-purified p53His175 mutant protein [J].
Cohen, PA ;
Hupp, TR ;
Lane, DP ;
Daniels, DA .
FEBS LETTERS, 1999, 463 (1-2) :179-184
[7]   The p53 Paddy Wagon - COP1, Pirh2 and MDM2 are found resisting apoptosis and growth arrest [J].
Corcoran, CA ;
Huang, Y ;
Sheikh, MS .
CANCER BIOLOGY & THERAPY, 2004, 3 (08) :721-725
[8]   Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers [J].
Craig, AL ;
Burch, L ;
Vojtesek, B ;
Mikutowska, J ;
Thompson, A ;
Hupp, TR .
BIOCHEMICAL JOURNAL, 1999, 342 :133-141
[9]   Inhibition of p53-dependent transcription by BOX-I phospho-peptide mimetics that bind to p300 [J].
Dornan, D ;
Hupp, TR .
EMBO REPORTS, 2001, 2 (02) :139-144
[10]   DNA-dependent acetylation of p53 by the transcription coactivator p300 [J].
Dornan, D ;
Shimizu, H ;
Perkins, ND ;
Hupp, TR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (15) :13431-13441